Eun-Hee Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Eun-Hee Kim has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Heeyoun Hwang
Digital Omics Research Center, Korea Basic Science Institute
1 shared publication - Jihyun Im
Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Korea
1 shared publication - Jikyo Lee
Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea
1 shared publication - Joon Hee Lee
Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea
1 shared publication - Jung Hoon Choi
Digital Omics Research Center, Korea Basic Science Institute (KBSI), Cheongju 28119, Republic of Korea
1 shared publication - Junghan Song
Department of Laboratory Medicine, Seoul National University Bundang Hospital and College of Medicine, Seongnam, Korea
1 shared publication
Latest Publications
- 20 August 2024
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 44 (6) , 518-528
Detecting M-Protein via Mass Spectrometry and Affinity Beads: Enrichment With Mixed Kappa-Lambda Beads Enables Prompt Application in Clinical Laboratories
Background: Detecting monoclonal protein (M-protein), a hallmark of plasma cell disorders, traditionally relies on methods such as protein electrophoresis, immune-electrophosuch as matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) and electrospray ionization-quadrupole time-of-flight (ESI-qTOF) MS, have emerged as sensitive methods. We explored the M-protein-detection efficacies of different MS techniques. Methods: To isolate immunoglobulin and light chain proteins, six types of beads (IgG, IgA, IgM, kappa, lambda, and mixed kappa and lambda) were used to prepare samples along with CaptureSelect nanobody affinity beads (NBs). After purification, both MALDI-TOF MS and liquid chromatography coupled with Synapt G2 ESI-qTOF high-resolution MS analysis were performed. We purified 25 normal and 25 abnormal IFE samples using NBs and Results: Abnormal samples showed monoclonal peaks, whereas normal samples showed polyclonal peaks. The IgG and mixed kappa and lambda beads showed monoclonal peaks following the use of daratumumab (an IgG/kappa type of monoclonal antibody) with both MALDI-TOF and ESI-qTOF MS analysis. The limits of detection for MALDI-TOF MS and ESIqTOF MS were established as 0.1 g/dL and 0.025 g/dL, respectively. Conclusions: NB-MALDI-TOF and IFE exhibited comparable sensitivity and specificity (92% and 92%, respectively). identified monoclonal peaks with both MALDI-TOF and ESI-qTOF analyses. Qualitative analysis using MALDI-TOF yielded results comparable with that of IFE. NB-MALDI-TOF might be used as an alternative method to replace conventional tests (such as IFE) to detect M-pro
- 20 August 2024
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 44 (6) , 518-528
Detecting M-Protein via Mass Spectrometry and Affinity Beads: Enrichment With Mixed Kappa-Lambda Beads Enables Prompt Application in Clinical Laboratories
Background: Detecting monoclonal protein (M-protein), a hallmark of plasma cell disorders, traditionally relies on methods such as protein electrophoresis, immune-electrophosuch as matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) and electrospray ionization-quadrupole time-of-flight (ESI-qTOF) MS, have emerged as sensitive methods. We explored the M-protein-detection efficacies of different MS techniques. Methods: To isolate immunoglobulin and light chain proteins, six types of beads (IgG, IgA, IgM, kappa, lambda, and mixed kappa and lambda) were used to prepare samples along with CaptureSelect nanobody affinity beads (NBs). After purification, both MALDI-TOF MS and liquid chromatography coupled with Synapt G2 ESI-qTOF high-resolution MS analysis were performed. We purified 25 normal and 25 abnormal IFE samples using NBs and Results: Abnormal samples showed monoclonal peaks, whereas normal samples showed polyclonal peaks. The IgG and mixed kappa and lambda beads showed monoclonal peaks following the use of daratumumab (an IgG/kappa type of monoclonal antibody) with both MALDI-TOF and ESI-qTOF MS analysis. The limits of detection for MALDI-TOF MS and ESIqTOF MS were established as 0.1 g/dL and 0.025 g/dL, respectively. Conclusions: NB-MALDI-TOF and IFE exhibited comparable sensitivity and specificity (92% and 92%, respectively). identified monoclonal peaks with both MALDI-TOF and ESI-qTOF analyses. Qualitative analysis using MALDI-TOF yielded results comparable with that of IFE. NB-MALDI-TOF might be used as an alternative method to replace conventional tests (such as IFE) to detect M-pro